StockNews.com Upgrades Lakeland Industries (NASDAQ:LAKE) to "Sell"

Lakeland Industries (NASDAQ:LAKE - Get Free Report) was upgraded by stock analysts at StockNews.com to a "sell" rating in a report issued on Wednesday.

LAKE has been the subject of several other reports. DA Davidson decreased their target price on shares of Lakeland Industries from $28.00 to $23.00 and set a "buy" rating for the company in a research report on Tuesday, April 15th. Lake Street Capital began coverage on Lakeland Industries in a report on Tuesday, March 11th. They set a "buy" rating and a $30.00 price objective for the company. One analyst has rated the stock with a sell rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, Lakeland Industries presently has an average rating of "Moderate Buy" and a consensus target price of $27.00.

Lakeland Industries Stock Performance

Shares of LAKE opened at $16.03 on Wednesday. The stock has a 50-day moving average of $18.43 and a 200-day moving average of $21.42. Lakeland Industries has a one year low of $14.58 and a one year high of $27.28. The company has a debt-to-equity ratio of 0.25, a current ratio of 4.23 and a quick ratio of 1.77. The company has a market cap of $152.27 million, a PE ratio of -178.11 and a beta of 1.10.

Lakeland Industries (NASDAQ:LAKE - Get Free Report) last released its quarterly earnings data on Wednesday, April 9th. The medical instruments supplier reported ($0.54) EPS for the quarter, missing the consensus estimate of $0.43 by ($0.97). Lakeland Industries had a negative net margin of 0.42% and a positive return on equity of 1.66%. The firm had revenue of $46.60 million for the quarter, compared to the consensus estimate of $47.10 million. During the same quarter in the prior year, the firm earned $0.72 EPS. On average, equities research analysts predict that Lakeland Industries will post 0.48 EPS for the current fiscal year.

Institutional Investors Weigh In On Lakeland Industries

Large investors have recently made changes to their positions in the business. Private Capital Management LLC increased its holdings in Lakeland Industries by 0.4% during the fourth quarter. Private Capital Management LLC now owns 1,007,391 shares of the medical instruments supplier's stock worth $25,739,000 after buying an additional 4,092 shares during the last quarter. Royce & Associates LP increased its stake in shares of Lakeland Industries by 9.4% during the 1st quarter. Royce & Associates LP now owns 931,920 shares of the medical instruments supplier's stock worth $18,927,000 after purchasing an additional 79,940 shares during the last quarter. Ancora Advisors LLC raised its holdings in shares of Lakeland Industries by 112.5% in the 4th quarter. Ancora Advisors LLC now owns 149,493 shares of the medical instruments supplier's stock worth $3,820,000 after purchasing an additional 79,148 shares during the period. Susquehanna International Group LLP lifted its stake in Lakeland Industries by 261.9% in the fourth quarter. Susquehanna International Group LLP now owns 98,419 shares of the medical instruments supplier's stock valued at $2,515,000 after purchasing an additional 71,224 shares during the last quarter. Finally, Peapod Lane Capital LLC purchased a new position in Lakeland Industries in the fourth quarter valued at approximately $2,018,000. 71.69% of the stock is owned by hedge funds and other institutional investors.

About Lakeland Industries

Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.